Venous Stasis Ulcer
Aka: Venous Stasis Ulcer, Venous Ulcer, Varicose Ulcer
II. Epidemiology
- More common in women
- Prevalence: 1-3% in U.S. (4% of those over age 65 years)
III. Pathophysiology
- See Venous Insufficiency
- Venous Stasis Ulcers form in areas of venous Hypertension
- Higher venous pressures are due to venous reflux or venous obstruction
- Venous circulation inflammation (vein wall, or venous valve leaflets)
- Inflammatory factors extravasate into the interstitial space
IV. Risk Factors
- Over age 55 years
- Prior leg injury
- Obesity
- Phlebitis
- Varicose Veins or related surgery
- Prolonged standing or sitting
- Deep Vein Thrombosis history
- Family History of Chronic Venous Insufficiency or parental history of Venous Ulcers
- Multiple pregnancies
- Severe Lipodermatosclerosis (Panniculitis with secondary skin hardening and swelling)
V. Symptoms
VI. Signs
- Medial malleolus most often affected
- Irregular, flat, well-defined border
- Associated findings (see Venous Insufficiency)
- Dependent Edema
- Varicose Veins
- Purpura
- Red-brown Skin Discoloration
- Venous Dermatitis (Eczematous changes)
VII. Differential Diagnosis
- See Leg Ulcer Causes
- See Foot Ulcer
- See Skin Ulcer
- Arterial Insufficiency related ulcer
- Vasculitic Disease related ulcer
- Peripheral Neuropathy related ulcer
- Pressure Ulcer
- Skin malignancy
- Pyoderma Gangrenosum
- Skin Ulcers related to other conditions
- Calciphylaxis
- Vasculitis
- Autoimmune Conditions
- Sickle Cell Anemia
VIII. Evaluation: Non-healing ulcer
- Biopsy
- Evaluate for Vasculitis or malignancy
- Vascular evaluation
- Peripheral Arterial Disease
- Ankle-Brachial Index (ABI) or
- Arterial Doppler
- Venous Insufficiency confirmation (and exclude obstruction)
- Duplex Ultrasound
- Peripheral Arterial Disease
IX. Management: First-line options (most effective measures)
- General measures
- Keep leg up above heart level 30 minutes 3-4 times/day, for 6 days per week
- Progressive resistance Exercises (e.g. ankle Exercises) and prescribed Physical Activity (e.g. walking)
- Maintain moist wound environment (e.g. Aquaphor)
- Debride slough and necrotic tissues
- See Wound Cleansing
- See Wound Debridement
- Sharp Debridement, Enzymatic Debridement and Autolytic Debridement are preferred over Mechanical Debridement
- Mechanical Debridement (Wet-to-Dry Dressings, pulsed lavage, whirlpool) is used less than other methods
- However, Wet-to-Dry Dressings are among the most cost effective measures (see below)
- Purely Venous Stasis Ulcers need minimal debridement
- If significant debridement required than consider alternative diagnoses
- Wound Debridement at each provider visit results in reduced wound size
- Compression of edematous limb (e.g. elastic graded-Compression stockings)
- See Compression stockings
- See Venous Insufficiency
- Contraindicated in Peripheral Arterial Disease and uncompensated Congestive Heart Failure
- Limited use if wound drainage, significant pain, leg deformity and difficulty self-applying compression
- Donning butler or stockings with easier closure (e.g. velcro or zipper) may be considered
- Most effective strategy, but adequate pressures must be reached (30-44 mmHg are preferred at knee and hip)
- Compression stockings are removed each night
- Replace with new Compression stockings every 6 months (compression lost as they are repeatedly washed)
- Multi-layer compression systems (with an elastic component) are most effective
- Dressings
- No advantage of one type dressing versus another
- Options
- Wet-to-Moist Dressings are most cost-effective
- Similar efficacy to more expensive options
- However,
- Vaseline-gauze (Adaptic)
- Occlusive hydrocolloid (e.g. Duoderm)
- May be more convenient and better pain reduction
- Agents lower colonized Bacterial load
- Silver products (e.g. Acticoat)
- Xeroform
- Wet-to-Moist Dressings are most cost-effective
- Example Dressing
- Layer 1: Hydrogel Dressing (e.g. Duoderm Gel)
- Layer 2: Foam Dressing
- Layer 3: Compression Wrap
X. Management: Systemic Medications
- Antibiotics
- Decide if antibiotics are appropriate
- Most lesions are chronically colonized
- Antibiotics do not sterilize lesions
- Treat acute infections (Cellulitis)
- Base antibiotic use on tissue culture
- Decide if antibiotics are appropriate
- Adjuncts
- Pentoxifylline (Trental)
- Cost effective adjunct speeds Venous Ulcer healing
- Jull (2002) Lancet 359:1550-4 [PubMed]
- Aspirin 325 mg daily
- Consider as alternative agent to Trental (variable evidence)
- Statins
- Limited evidence of improved ulcer healing
- Evangelista (2014) Br J Dermatol 170(5): 1151-7 [PubMed]
- Pentoxifylline (Trental)
XI. Management: Second-line options
- Cellular and tissue based products (the following are examples, not a complete list)
- Cultured allogenic bilayer skin replacement
- Peri-ulcer injection
- Granulocyte–Macrophage Colony Stimulating Factor
- Systemic Mesoglycan
- Skin grafting
- Indicated in large Venous Ulcers >25 cm^2
- Not effective if edema persists or underlying Venous Insufficiency goes untreated
- Endovenous intervention
- Endovenous ablation, ligation or sclerotherapy
XII. Management: Strategies with unknown efficacy or mixed results
- Unna Boot
- Contraindicated if significant wound drainage
- Graduated compression
- Maximal compression at ankle
- No compression at top of boot (contrast with elastic compression stocking)
- Silver sulfadiazine
- Unclear whether improves Wound Healing
- Topical Autologous Platelet Lysate
- Approved for diabetic wounds only
- Hydrocolloid Dressings
- Hyperbaric oxygen
- No proven benefit
- Vacuum assisted wound closure (VAC)
- Insufficient evidence to support use in terms of clinically useful outcomes
- Oral Sulodexide
- Phlebotonics
- Do not appear to improve Venous Ulcer healing (but may improve edema and symptoms)
- Oral flavinoids (rutosides, diosmin, hesperidin)
- Saponins (Horse chestnut seed extract)
XIII. Management: Stratagies to avoid
- Avoid Topical Antibiotics
- Antibiotics do not improve ulcer healing
- Avoid Topical antiseptics (e.g. povidone-Iodine)
- Causes wound injury and delays healing
XIV. Course
- Heals with treatment at 40 to 120 days in most cases
- Persistent ulcer at one year in 25% of cases
- Recurrence of Venous Ulcers in up to 70% of cases
XV. Prognosis: Predictors of worse prognosis
- Venous Ulcer present >3 months
- Venous Ulcer longer than 10 cm
- Lower extremity Peripheral Arterial Disease
- Obesity
- Advanced age
XVI. Complications
- Infection
- Squamous cell cancer
- Venous Ulcer related Chronic Pain
XVII. Prevention
- Compression stockings prevent ulcer recurrence (contraindicated if ABI <0.8)
- Consider venous recanalization for venous obstruction
- Consider venous ablation for venous incompetency
XVIII. References
- Abbade (2005) Int J Dermatol 44(6): 449-56 [PubMed]
- Collins (2010) Am Fam Physician 81(8): 989-6 [PubMed]
- De Araujo (2003) Ann Intern Med 138:326-34 [PubMed]
- Etufugh (2007) Clin Dermatol 25(1): 121-30 [PubMed]
- Millan (2019) Am Fam Physician 100(5): 298-305 [PubMed]
- Nelson (2005) Am Fam Physician 71(7):1365-66 [PubMed]
- Weingarten (2001) Clin Infect Dis 32:949-54 [PubMed]